Authors:
BROSTROM C
SONNERBORG A
LINDBACK S
GAINES H
Citation: C. Brostrom et al., LOW RELATIVE FREQUENCIES OF CD26(-TERM NONPROGRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS() CD4(+) CELLS IN LONG), Clinical and diagnostic laboratory immunology, 5(5), 1998, pp. 662-666
Authors:
THORSTENSSON R
ANDERSSON S
LINDBACK S
DIAS F
MHALU F
GAINES H
BIBERFELD G
Citation: R. Thorstensson et al., EVALUATION OF 14 COMMERCIAL HIV-1 HIV-2 ANTIBODY-ASSAYS USING SERUM PANELS OF DIFFERENT GEOGRAPHICAL ORIGIN AND CLINICAL STAGE INCLUDING A UNIQUE SEROCONVERSION PANEL/, Journal of virological methods, 70(2), 1998, pp. 139-151
Authors:
PEHRSON P
LINDBACK S
LIDMAN C
GAINES H
GIESECKE J
Citation: P. Pehrson et al., LONGER SURVIVAL AFTER HIV-INFECTION FOR INJECTING DRUG-USERS THAN FORHOMOSEXUAL MEN - IMPLICATIONS FOR IMMUNOLOGY, AIDS, 11(8), 1997, pp. 1007-1012
Authors:
LAPINS J
LINDBACK S
LIDBRINK P
BIBERFELD P
EMTESTAM L
GAINES H
Citation: J. Lapins et al., MUCOCUTANEOUS MANIFESTATIONS IN 22 CONSECUTIVE CASES OF PRIMARY HIV-1INFECTION, British journal of dermatology, 134(2), 1996, pp. 257-261
Authors:
LINDBACK S
BROSTROM C
KARLSSON A
GAINES H
Citation: S. Lindback et al., DOES SYMPTOMATIC PRIMARY HIV-1 INFECTION ACCELERATE PROGRESSION TO CDC STAGE-IV DISEASE, CD4 COUNT BELOW 200 X 10(6) 1, AIDS, AND DEATH FROM AIDS/, BMJ. British medical journal, 309(6968), 1994, pp. 1535-1537
Authors:
LIDMAN C
BERGLUND O
TYNELL E
LINDBACK S
ELVIN K
Citation: C. Lidman et al., AEROSOLIZED PENTAMIDINE AS PRIMARY PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA - EFFICACY, MORTALITY AND MORBIDITY, AIDS, 8(7), 1994, pp. 935-939
Citation: C. Lidman et al., AEROSOLIZED PENTAMIDINE VERSUS IV PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA, Infection, 21(3), 1993, pp. 146-149